Market Cap 10.47M
Revenue (ttm) 400,000.00
Net Income (ttm) -8.98M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,245.00%
Debt to Equity Ratio 0.00
Volume 8,809
Avg Vol 59,476
Day's Range N/A - N/A
Shares Out 8.88M
Stochastic %K 71%
Beta 0.28
Analysts Strong Sell
Price Target $13.00

Company Profile

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. It develops programs relate to the treatment of disc/spine disease and metabolic disorders. The company's products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral di...

Industry: Biotechnology
Sector: Healthcare
Phone: 631 760 8100
Address:
40 Marcus Drive, Suite 1, Melville, United States
Black_Jobs
Black_Jobs Jan. 6 at 7:54 PM
$BRTX When you don't know, ask. We are waiting on the Type B results for BRTX - 100. We, specifically, want to know about the accelerated BLA pathway and if they moved it up anymore. This could be a positive catalyst.
1 · Reply
SmutBrigade
SmutBrigade Jan. 6 at 3:10 AM
$BRTX There's no definitive link between the release of Type B meeting minutes and an increase in stock price. What you're all looking for is 6 and 12 months after the last patient has been enrolled. You're welcome.
1 · Reply
Black_Jobs
Black_Jobs Jan. 5 at 11:58 PM
$BRTX The Type B meeting results could/should be coming out any day now. WTH is taking so long? I wish I could buy a million dollars worth of this stock.
0 · Reply
daytraderforplayandprofi
daytraderforplayandprofi Dec. 29 at 7:32 PM
$BRTX still haven’t heard anything wrong with this company yet, only good - soooo….
0 · Reply
SyntaxSaga
SyntaxSaga Dec. 27 at 2:24 PM
$BRTX Valuation sensitivity is high because visibility is uneven; commercial execution has to tighten in upcoming quarters — any stumble could quickly widen valuation discounts. From here, results — not promises — will decide direction.
0 · Reply
MrTicker
MrTicker Dec. 19 at 8:21 PM
$BRTX New 13G Todd Morrison , 7.7% stake , 685k shares.
0 · Reply
MrTicker
MrTicker Dec. 19 at 8:20 PM
$BRTX Form SCHEDULE 13G/A BioRestorative Therapies Filed by: Morrison Todd Hale 10K WIZARD 2:06 PM ET 12/19/2025 http://archive.fast-edgar.com/20251219/AWZZT22MS222P222222D22Z2RU8MZ2282472 Filed on: December 19, 2025
0 · Reply
LamBrad
LamBrad Dec. 18 at 3:59 PM
$BRTX Still low volume, but finally some movement!
0 · Reply
chrsc
chrsc Dec. 18 at 3:23 PM
$BRTX something going on for sure. wonder if the FDA meeting went well…
1 · Reply
NovaX234
NovaX234 Dec. 16 at 10:00 PM
$BRTX pretty quiet in here
0 · Reply
Latest News on BRTX
BioRestorative Announces Share Repurchase Program

Jun 17, 2025, 9:25 AM EDT - 7 months ago

BioRestorative Announces Share Repurchase Program


Black_Jobs
Black_Jobs Jan. 6 at 7:54 PM
$BRTX When you don't know, ask. We are waiting on the Type B results for BRTX - 100. We, specifically, want to know about the accelerated BLA pathway and if they moved it up anymore. This could be a positive catalyst.
1 · Reply
SmutBrigade
SmutBrigade Jan. 6 at 3:10 AM
$BRTX There's no definitive link between the release of Type B meeting minutes and an increase in stock price. What you're all looking for is 6 and 12 months after the last patient has been enrolled. You're welcome.
1 · Reply
Black_Jobs
Black_Jobs Jan. 5 at 11:58 PM
$BRTX The Type B meeting results could/should be coming out any day now. WTH is taking so long? I wish I could buy a million dollars worth of this stock.
0 · Reply
daytraderforplayandprofi
daytraderforplayandprofi Dec. 29 at 7:32 PM
$BRTX still haven’t heard anything wrong with this company yet, only good - soooo….
0 · Reply
SyntaxSaga
SyntaxSaga Dec. 27 at 2:24 PM
$BRTX Valuation sensitivity is high because visibility is uneven; commercial execution has to tighten in upcoming quarters — any stumble could quickly widen valuation discounts. From here, results — not promises — will decide direction.
0 · Reply
MrTicker
MrTicker Dec. 19 at 8:21 PM
$BRTX New 13G Todd Morrison , 7.7% stake , 685k shares.
0 · Reply
MrTicker
MrTicker Dec. 19 at 8:20 PM
$BRTX Form SCHEDULE 13G/A BioRestorative Therapies Filed by: Morrison Todd Hale 10K WIZARD 2:06 PM ET 12/19/2025 http://archive.fast-edgar.com/20251219/AWZZT22MS222P222222D22Z2RU8MZ2282472 Filed on: December 19, 2025
0 · Reply
LamBrad
LamBrad Dec. 18 at 3:59 PM
$BRTX Still low volume, but finally some movement!
0 · Reply
chrsc
chrsc Dec. 18 at 3:23 PM
$BRTX something going on for sure. wonder if the FDA meeting went well…
1 · Reply
NovaX234
NovaX234 Dec. 16 at 10:00 PM
$BRTX pretty quiet in here
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 16 at 12:17 PM
$BRTX reverse park job 1.09-1.12 old cyth and jagx
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 16 at 12:17 PM
$BRTX given u old nvcn code temp and right of passage to use it shared with opk
1 · Reply
Black_Jobs
Black_Jobs Dec. 8 at 1:10 PM
$BRTX This is only the beginning. They will have a positive Type B meeting with the FDA. They have crushed every other report on Phase 2 for BTRX-100. I hope it goes to $10 when they announce. buy now
2 · Reply
chrsc
chrsc Dec. 4 at 8:10 PM
$BRTX should trade back up to the offering price of $1.60 at a minimum…. but $2-3 before FDA meeting is pretty likely.
1 · Reply
chrsc
chrsc Dec. 2 at 3:01 PM
Added to $IREN $FOUR $BRTX and $UBER this morning.
0 · Reply
chrsc
chrsc Dec. 1 at 5:48 PM
$BRTX just added 10k shares. Got too cheap again.
0 · Reply
daytraderforplayandprofi
daytraderforplayandprofi Nov. 24 at 9:04 PM
$BRTX nothing solid is bringing this stock down. Its got a lot of grip to make it rise. Its a buy lol
0 · Reply
gobuckeyes21
gobuckeyes21 Nov. 20 at 7:32 PM
$BRTX under a dollar soon. Another pump and dump coming but will further retreat after. Lance the conman continues to impress!
0 · Reply
stockwitsuser2449
stockwitsuser2449 Nov. 20 at 7:01 PM
0 · Reply
Black_Jobs
Black_Jobs Nov. 20 at 6:12 PM
$BRTX This was a surprise. All of their FDA scheduled check is have been way off the charts. They have a meeting in December to further accelerate the process of FDA approval that's been fast tracked already. This, 100%, will be approved. I don't understand folks. They did a 600K offering for 1.1 million dollars and the ppl reacted like they are gouging shareholders. For what this company offers, they have been less than modest in dilution. I see worse everyday. This will make a full recovery. I'm buying more.
0 · Reply
UgoGreg
UgoGreg Nov. 20 at 3:43 PM
$BRTX https://youtu.be/IWUDcOr9Xqo
0 · Reply
LamBrad
LamBrad Nov. 19 at 11:28 PM
$BRTX Interesting spike at close - more to come?
0 · Reply